2nd Dermatology Drug Development Summit Europe 2021 | Virtual Event

Bernat Vidal

External Research & Innovation Manager

Almirall

Betsy Hughes-Formella

Independent Consultant

Dermatology Drug Development

Julien Seneschal

Professor of Dermatology

Bordeaux University

Christian Loesche

Translational Medicine Lead Dermatology

Novartis

Dirk Brockstedt

Chief Scientific Officer

RAPT Therapeutics

Dogan Fidan

Head of Global Strategic Franchise, Immunology & Inflammation

Galderma

Enikö Sonkoly

Senior Lecturer, Dermatologist

Karolinska institutet

Ernst Kriehuber

Vice President, Head of Translational, Medicine- Immunology

UCB

Fiona Kuo

Director, Clinical Science

Incyte

Frank Sinner

Director, Institute for Biomedicine & Health Sciences

Joanneum Research

Gary Goldenberg

Chief Medical Officer

Verrica Pharmaceuticals

Jasmina Jankicevic

Dermatologist, Clinical Development & Medical Affairs

JJ Consulting

Janet König

Head, Unit on Anesthesiology/ Algesiology/Rheumatology/ Pulmonology/ENT

BfArM

Jean-François Ginglinger

Chief Scientific Officer

Temisis Therapeutics

Kendall Marcus

Director, Division of Dermatology & Dental Products

FDA

Mads Roepke

Senior Scientific Advisor

Leo Pharma

Matthew Callahan

Founder and Board Director

Botanix

Marta Bertolini

Principal Scientist and Deputy General Manager

Monasterium Laboratory

Ofer Toledano

Vice President, Research & Development

Sol-Gel Technologies

Patrick M. Brunner

Associate Professor

Medical University of Vienna

Robert Rissman

Research Director

Dermatology Center for Human Drug Research

Sylvie Gabriel

Head of Market Access, Pricing & HEOR

Galderma

Yiumo Chan

Senior Director

TWi Biotechnology, Inc

David Bower

Global Value & Access Lead for Dupixent - Dermatology

Sanofi Genzyme

Nicolas Dapis

Chief Business Officer (CBO), Clinical Services

QuantifiCare

Gareth Winckle

Head of Formulation

Nuvisan Pharma Services

Jean-Guy Boiteau

Head Chemical Development